dihexa cognitive benefits latest Methylene Blue & for Brain Health AngIV-Analog Dihexa Rescues Cognitive Impairment

When Peptide Therapy Makes Sense Theres a lot of nuance

The peptides ability to produce metabolic effects with such rapid plasma clearance (3-minute half-life) while maintaining prolonged biological activity represents a significant knowledge gap requiring further investigation

A recent phase 2 trial investigated the triple biased GLP-1/GIP/GCC receptors agonist retatrutide (LY3437943) in 338 patients with a mean age of 48 years and BMI of 37.3 kg/m 2 without diabetes (prediabetes in 36% participants) showing BW and WC reduction ranging from 8.7% to 24.2% and 6.5 cm to 19.6 cm in the 1 mg and 12 mg dose groups, respectively, at 48 weeks 41

Both peptides are not approved for routine human use (sold for research purposes) and are banned in competitive sports [10]